Phase 3 Study Evaluating Efficacy, Safety and Pharmacokinetics of Trilaciclib In Small Cell Lung Cancer Patients

Clinical trial NCT04902885 · COMPLETED

Trial details

NCT number: NCT04902885
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Extensive-stage Small-cell Lung Cancer

Start date: 2021-05-25
Primary completion: 2021-12-29
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.